Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Robert Naclerio to Nasal Provocation Tests

This is a "connection" page, showing publications Robert Naclerio has written about Nasal Provocation Tests.

 
Connection Strength
 
 
 
6.551
 
  1. Baroody FM, Gavanescu L, Wang JH, DeTineo M, Naclerio RM. The effect of intranasal carbon dioxide on the acute response to nasal challenge with allergen. Allergy Asthma Proc. 2011 May-Jun; 32(3):206-12.
    View in: PubMed
    Score: 0.463
  2. Vishwanath S, Baroody FM, Chaaban MR, deTineo M, Lasser KH, Lasser EC, Naclerio RM. Topical intranasal ioxaglate meglumine 39.3% and ioxaglate sodium 19.6% (Hexabrix) reduces the acute response to nasal challenge with allergen. J Allergy Clin Immunol. 2011 Jul; 128(1):219-21.
    View in: PubMed
    Score: 0.459
  3. Naclerio RM, Pinto J, deTineo M, Baroody FM. Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis. Allergy Asthma Proc. 2008 Jan-Feb; 29(1):24-8.
    View in: PubMed
    Score: 0.367
  4. Assanasen P, Baroody FM, Naureckas E, Naclerio RM. Hot, humid air increases cellular influx during the late-phase response to nasal challenge with antigen. Clin Exp Allergy. 2001 Dec; 31(12):1913-22.
    View in: PubMed
    Score: 0.241
  5. Assanasen P, Baroody FM, Naureckas E, Naclerio RM. Warming of feet elevates nasal mucosal surface temperature and reduces the early response to nasal challenge with allergen. J Allergy Clin Immunol. 1999 Aug; 104(2 Pt 1):285-93.
    View in: PubMed
    Score: 0.205
  6. Baroody FM, Ford S, Proud D, Kagey-Sobotka A, Lichtenstein L, Naclerio RM. Relationship between histamine and physiological changes during the early response to nasal antigen provocation. J Appl Physiol (1985). 1999 Feb; 86(2):659-68.
    View in: PubMed
    Score: 0.198
  7. Naclerio RM, Adkinson NF, Moylan B, Baroody FM, Proud D, Kagey-Sobotka A, Lichtenstein LM, Hamilton R. Nasal provocation with allergen induces a secondary serum IgE antibody response. J Allergy Clin Immunol. 1997 Oct; 100(4):505-10.
    View in: PubMed
    Score: 0.180
  8. Wagenmann M, Baroody FM, Desrosiers M, Hubbard WC, Ford S, Lichtenstein LM, Naclerio RM. Unilateral nasal allergen challenge leads to bilateral release of prostaglandin D2. Clin Exp Allergy. 1996 Apr; 26(4):371-8.
    View in: PubMed
    Score: 0.163
  9. Baroody FM, Lim MC, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Effects of loratadine and terfenadine on the induced nasal allergic reaction. Arch Otolaryngol Head Neck Surg. 1996 Mar; 122(3):309-16.
    View in: PubMed
    Score: 0.162
  10. Baroody FM, Driscoll PV, Moylan B, Fleming L, Shilstone J, Naclerio RM. Duration of action of intranasal atropine on methacholine-induced nasal secretions. Arch Otolaryngol Head Neck Surg. 1996 Mar; 122(3):321-3.
    View in: PubMed
    Score: 0.162
  11. Desrosiers M, Proud D, Naclerio RM. Lack of effect of hot, humid air on response to nasal challenge with histamine. Ann Otol Rhinol Laryngol. 1996 Feb; 105(2):146-54.
    View in: PubMed
    Score: 0.161
  12. Baroody FM, Ford S, Lichtenstein LM, Kagey-Sobotka A, Naclerio RM. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine. Am J Respir Crit Care Med. 1994 Jun; 149(6):1457-65.
    View in: PubMed
    Score: 0.143
  13. Wagenmann M, Baroody FM, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. The effect of terfenadine on unilateral nasal challenge with allergen. J Allergy Clin Immunol. 1994 Mar; 93(3):594-605.
    View in: PubMed
    Score: 0.141
  14. Shin MH, Averill FJ, Hubbard WC, Chilton FH, Baroody FM, Liu MC, Naclerio RM. Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine. Am J Respir Crit Care Med. 1994 Mar; 149(3 Pt 1):660-6.
    View in: PubMed
    Score: 0.141
  15. Naclerio RM. Effects of antihistamines on inflammatory mediators. Ann Allergy. 1993 Sep; 71(3):292-5.
    View in: PubMed
    Score: 0.136
  16. Baroody FM, Detineo M, Naclerio RM. Unilateral nasal allergic reactions increase bilateral sinus eosinophil infiltration. J Appl Physiol (1985). 2013 Nov 01; 115(9):1262-7.
    View in: PubMed
    Score: 0.136
  17. Jankowski R, Wagenmann M, Baroody FM, Naclerio R. Effect of terfenadine on nasal provocation. Int Arch Allergy Immunol. 1993; 101(3):311-7.
    View in: PubMed
    Score: 0.130
  18. Naclerio RM. Inhibition of mediator release during the early reaction to antigen. J Allergy Clin Immunol. 1992 Oct; 90(4 Pt 2):715-9.
    View in: PubMed
    Score: 0.128
  19. Majchel AM, Proud D, Freidhoff L, Creticos PS, Norman PS, Naclerio RM. The nasal response to histamine challenge: effect of the pollen season and immunotherapy. J Allergy Clin Immunol. 1992 Jul; 90(1):85-91.
    View in: PubMed
    Score: 0.125
  20. Baroody FM, Mucha SM, deTineo M, Naclerio RM. Evidence of maxillary sinus inflammation in seasonal allergic rhinitis. Otolaryngol Head Neck Surg. 2012 Jun; 146(6):880-6.
    View in: PubMed
    Score: 0.122
  21. Walden SM, Proud D, Lichtenstein LM, Kagey-Sobotka A, Naclerio RM. Antigen-provoked increase in histamine reactivity. Observations on mechanisms. Am Rev Respir Dis. 1991 Sep; 144(3 Pt 1):642-8.
    View in: PubMed
    Score: 0.118
  22. Iliopoulos O, Proud D, Adkinson NF, Creticos PS, Norman PS, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol. 1991 Apr; 87(4):855-66.
    View in: PubMed
    Score: 0.115
  23. Flowers BK, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Localized antigen challenge of the nasal mucosa. Arch Otolaryngol Head Neck Surg. 1990 Dec; 116(12):1407-10.
    View in: PubMed
    Score: 0.112
  24. Iliopoulos O, Proud D, Adkinson NF, Norman PS, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Relationship between the early, late, and rechallenge reaction to nasal challenge with antigen: observations on the role of inflammatory mediators and cells. J Allergy Clin Immunol. 1990 Dec; 86(6 Pt 1):851-61.
    View in: PubMed
    Score: 0.112
  25. Togias A, Lykens K, Kagey-Sobotka A, Eggleston PA, Proud D, Lichtenstein LM, Naclerio RM. Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose. Am Rev Respir Dis. 1990 Jun; 141(6):1428-33.
    View in: PubMed
    Score: 0.109
  26. Baroody FM, Shenaq D, DeTineo M, Wang J, Naclerio RM. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol. 2009 Jun; 123(6):1342-8.
    View in: PubMed
    Score: 0.101
  27. Walden SM, Proud D, Bascom R, Lichtenstein LM, Kagey-Sobotka A, Adkinson NF, Naclerio RM. Experimentally induced nasal allergic responses. J Allergy Clin Immunol. 1988 May; 81(5 Pt 2):940-9.
    View in: PubMed
    Score: 0.094
  28. Baroody FM, Mucha SM, Detineo M, Naclerio RM. Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol. 2008 May; 121(5):1126-1132.e7.
    View in: PubMed
    Score: 0.093
  29. Proud D, Reynolds CJ, Lacapra S, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis. 1988 Mar; 137(3):613-6.
    View in: PubMed
    Score: 0.093
  30. Baroody FM, Foster KA, Markaryan A, deTineo M, Naclerio RM. Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2008 Mar; 100(3):194-9.
    View in: PubMed
    Score: 0.093
  31. Togias A, Naclerio RM. Cold air-induced rhinitis. Clin Allergy Immunol. 2007; 19:267-81.
    View in: PubMed
    Score: 0.086
  32. Naclerio RM, Creticos PS, Norman PS, Lichtenstein LM. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1986 Nov; 134(5):1102.
    View in: PubMed
    Score: 0.085
  33. Kirtsreesakul V, Luxameechanporn T, Klemens JJ, Thompson K, Naclerio RM. Effect of genetic background on the response to bacterial sinusitis in mice. Arch Otolaryngol Head Neck Surg. 2006 Oct; 132(10):1102-8.
    View in: PubMed
    Score: 0.084
  34. Saengpanich S, Assanasen P, deTineo M, Haney L, Naclerio RM, Baroody FM. Effects of intranasal azelastine on the response to nasal allergen challenge. Laryngoscope. 2002 Jan; 112(1):47-52.
    View in: PubMed
    Score: 0.061
  35. Kaszuba SM, Baroody FM, deTineo M, Haney L, Blair C, Naclerio RM. Superiority of an intranasal corticosteroid compared with an oral antihistamine in the as-needed treatment of seasonal allergic rhinitis. Arch Intern Med. 2001 Nov 26; 161(21):2581-7.
    View in: PubMed
    Score: 0.060
  36. Assanasen P, Baroody FM, Abbott DJ, Naureckas E, Solway J, Naclerio RM. Natural and induced allergic responses increase the ability of the nose to warm and humidify air. J Allergy Clin Immunol. 2000 Dec; 106(6):1045-52.
    View in: PubMed
    Score: 0.056
  37. Naclerio RM, Proud D, Moylan B, Balcer S, Freidhoff L, Kagey-Sobotka A, Lichtenstein LM, Creticos PS, Hamilton RG, Norman PS. A double-blind study of the discontinuation of ragweed immunotherapy. J Allergy Clin Immunol. 1997 Sep; 100(3):293-300.
    View in: PubMed
    Score: 0.045
  38. Wagenmann M, Baroody FM, Cheng CC, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Bilateral increases in histamine after unilateral nasal allergen challenge. Am J Respir Crit Care Med. 1997 Feb; 155(2):426-31.
    View in: PubMed
    Score: 0.043
  39. Naclerio RM, Hubbard W, Lichtenstein LM, Kagey-Sobotka A, Proud D. Origin of late phase histamine release. J Allergy Clin Immunol. 1996 Oct; 98(4):721-3.
    View in: PubMed
    Score: 0.042
  40. Naclerio RM, Proud D, Kagey-Sobotka A, Lichtenstein LM, Thompson M, Togias A. Cold dry air-induced rhinitis: effect of inhalation and exhalation through the nose. J Appl Physiol (1985). 1995 Aug; 79(2):467-71.
    View in: PubMed
    Score: 0.039
  41. Proud D, Bathon JM, Togias AG, Naclerio RM. Inhibition of the response to nasal provocation with bradykinin by HOE-140: efficacy and duration of action. Can J Physiol Pharmacol. 1995 Jul; 73(7):820-6.
    View in: PubMed
    Score: 0.039
  42. Naclerio RM, Baroody FM. In vivo human models for the study of anticholinergic drugs. J Allergy Clin Immunol. 1995 May; 95(5 Pt 2):1069-79.
    View in: PubMed
    Score: 0.038
  43. Lim MC, Taylor RM, Naclerio RM. The histology of allergic rhinitis and its comparison to cellular changes in nasal lavage. Am J Respir Crit Care Med. 1995 Jan; 151(1):136-44.
    View in: PubMed
    Score: 0.037
  44. Naclerio RM, Baroody FM, Kagey-Sobotka A, Lichtenstein LM. Basophils and eosinophils in allergic rhinitis. J Allergy Clin Immunol. 1994 Dec; 94(6 Pt 2):1303-9.
    View in: PubMed
    Score: 0.037
  45. Wagenmann M, Baroody FM, Jankowski R, Nadal JC, Roecker-Cooper M, Wood CC, Naclerio RM. Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions. Clin Exp Allergy. 1994 Mar; 24(3):288-90.
    View in: PubMed
    Score: 0.035
  46. Majchel AM, Baroody F, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Effect of oxymetazoline on the early response to nasal challenge with antigen. J Allergy Clin Immunol. 1993 Nov; 92(5):767-70.
    View in: PubMed
    Score: 0.034
  47. Jankowski R, Philip G, Togias A, Naclerio R. Demonstration of bilateral cholinergic secretory response after unilateral nasal cold, dry air challenge. Rhinology. 1993 Sep; 31(3):97-100.
    View in: PubMed
    Score: 0.034
  48. Naclerio RM. Immunologic changes after nasal provocation with allergen. Otolaryngol Head Neck Surg. 1993 Sep; 109(3 Pt 2):579-83.
    View in: PubMed
    Score: 0.034
  49. Naclerio RM, Baroody FM. Response of nasal mucosa to histamine or methacholine challenge: use of a quantitative method to examine the modulatory effects of atropine and ipratropium bromide. J Allergy Clin Immunol. 1992 Dec; 90(6 Pt 2):1051-4.
    View in: PubMed
    Score: 0.032
  50. Cruz AA, Togias AG, Lichtenstein LM, Kagey-Sobotka A, Proud D, Naclerio RM. Local application of atropine attenuates the upper airway reaction to cold, dry air. Am Rev Respir Dis. 1992 Aug; 146(2):340-6.
    View in: PubMed
    Score: 0.032
  51. Baroody FM, Majchel AM, Roecker MM, Roszko PJ, Zegarelli EC, Wood CC, Naclerio RM. Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine. J Allergy Clin Immunol. 1992 Jun; 89(6):1065-75.
    View in: PubMed
    Score: 0.031
  52. Proud D, Bailey GS, Naclerio RM, Reynolds CJ, Cruz AA, Eggleston PA, Lichtenstein LM, Togias AG. Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions. J Allergy Clin Immunol. 1992 Jun; 89(6):1098-110.
    View in: PubMed
    Score: 0.031
  53. Shin MH, Baroody F, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. The effect of azelastine on the early allergic response. Clin Exp Allergy. 1992 Feb; 22(2):289-95.
    View in: PubMed
    Score: 0.030
  54. Ford SA, Baroody FM, Naclerio RM. The impact of immunotherapy on the pathophysiology of ragweed pollen allergy. Rhinol Suppl. 1992; 14:52-6.
    View in: PubMed
    Score: 0.030
  55. Furin MJ, Norman PS, Creticos PS, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol. 1991 Jul; 88(1):27-32.
    View in: PubMed
    Score: 0.029
  56. Naclerio RM, Baroody FM, Togias AG. The role of leukotrienes in allergic rhinitis: a review. Am Rev Respir Dis. 1991 May; 143(5 Pt 2):S91-5.
    View in: PubMed
    Score: 0.029
  57. Cruz AA, Togias AG, Lichtenstein LM, Kagey-Sobotka A, Proud D, Naclerio RM. Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air. Am Rev Respir Dis. 1991 Apr; 143(4 Pt 1):761-5.
    View in: PubMed
    Score: 0.029
  58. Churchill L, Pongracic JA, Reynolds CJ, Naclerio RM, Proud D. Pharmacology of nasal provocation with bradykinin: studies of tachyphylaxis, cyclooxygenase inhibition, alpha-adrenergic stimulation, and receptor subtype. Int Arch Allergy Appl Immunol. 1991; 95(4):322-31.
    View in: PubMed
    Score: 0.028
  59. Majchel AM, Proud D, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM. Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen. Clin Exp Allergy. 1990 Nov; 20(6):701-5.
    View in: PubMed
    Score: 0.028
  60. Naclerio RM, Kagey-Sobotka A, Lichtenstein LM, Freidhoff L, Proud D. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis. 1990 Jul; 142(1):167-71.
    View in: PubMed
    Score: 0.027
  61. Creticos PS, Marsh DG, Proud D, Kagey-Sobotka A, Adkinson NF, Friedhoff L, Naclerio RM, Lichtenstein LM, Norman PS. Responses to ragweed-pollen nasal challenge before and after immunotherapy. J Allergy Clin Immunol. 1989 Aug; 84(2):197-205.
    View in: PubMed
    Score: 0.026
  62. Silber G, Proud D, Warner J, Naclerio R, Kagey-Sobotka A, Lichtenstein L, Eggleston P. In vivo release of inflammatory mediators by hyperosmolar solutions. Am Rev Respir Dis. 1988 Mar; 137(3):606-12.
    View in: PubMed
    Score: 0.023
  63. Pipkorn U, Granerus G, Proud D, Kagey-Sobotka A, Norman PS, Lichtenstein LM, Naclerio RM. The effect of a histamine synthesis inhibitor on the immediate nasal allergic reaction. Allergy. 1987 Oct; 42(7):496-501.
    View in: PubMed
    Score: 0.023
  64. Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. 1987 Jun 11; 316(24):1506-10.
    View in: PubMed
    Score: 0.022
  65. Brown MS, Peters SP, Adkinson NF, Proud D, Kagey-Sobotka A, Norman PS, Lichtenstein LM, Naclerio RM. Arachidonic acid metabolites during nasal challenge. Arch Otolaryngol Head Neck Surg. 1987 Feb; 113(2):179-83.
    View in: PubMed
    Score: 0.022
  66. Proud D, Kagey-Sobotka A, Naclerio RM, Lichtenstein LM. Pharmacology of upper airways challenge. Int Arch Allergy Appl Immunol. 1987; 82(3-4):493-7.
    View in: PubMed
    Score: 0.021
  67. Cruz AA, Naclerio RM, Proud D, Togias A. Epithelial shedding is associated with nasal reactions to cold, dry air. J Allergy Clin Immunol. 2006 Jun; 117(6):1351-8.
    View in: PubMed
    Score: 0.020
  68. Naclerio R, Proud D, Peters S, Sobotka AK, Lichtenstein L, Norman P. The role of inflammatory mediators in allergic rhinitis. Ear Nose Throat J. 1986 May; 65(5):206-12.
    View in: PubMed
    Score: 0.020
  69. Naclerio RM, Proud D, Peters SP, Silber G, Kagey-Sobotka A, Adkinson NF, Lichtenstein LM. Inflammatory mediators in nasal secretions during induced rhinitis. Clin Allergy. 1986 Mar; 16(2):101-10.
    View in: PubMed
    Score: 0.020
  70. Allocco FT, Votypka V, deTineo M, Naclerio RM, Baroody FM. Effects of fexofenadine on the early response to nasal allergen challenge. Ann Allergy Asthma Immunol. 2002 Dec; 89(6):578-84.
    View in: PubMed
    Score: 0.016
  71. Chung JH, deTineo ML, Naclerio RM, Sorrentino JV, Winslow CM, Baroody FM. Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction. Ann Allergy Asthma Immunol. 1997 Mar; 78(3):307-12.
    View in: PubMed
    Score: 0.011
  72. Stadel JM, Hoyle K, Naclerio RM, Roshak A, Chilton FH. Characterization of phospholipase A2 from human nasal lavage. Am J Respir Cell Mol Biol. 1994 Jul; 11(1):108-13.
    View in: PubMed
    Score: 0.009
  73. Hedlin G, Silber G, Naclerio R, Proud D, Lamas AM, Eggleston P, Adkinson NF. Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis. Clin Exp Allergy. 1990 Sep; 20(5):491-500.
    View in: PubMed
    Score: 0.007
  74. Hedlin G, Silber G, Schieken L, Naclerio R, Proud D, Eggleston P, Adkinson NF. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. J Allergy Clin Immunol. 1989 Sep; 84(3):390-9.
    View in: PubMed
    Score: 0.006
  75. Freeland HS, Pipkorn U, Schleimer RP, Bascom R, Lichtenstein LM, Naclerio RM, Peters SP. Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol. 1989 Mar; 83(3):634-42.
    View in: PubMed
    Score: 0.006
  76. Togias A, Naclerio RM, Proud D, Pipkorn U, Bascom R, Iliopoulos O, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Studies on the allergic and nonallergic nasal inflammation. J Allergy Clin Immunol. 1988 May; 81(5 Pt 1):782-90.
    View in: PubMed
    Score: 0.006
  77. Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli SJ, Lichtenstein LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol. 1988 Mar; 81(3):580-9.
    View in: PubMed
    Score: 0.006
  78. Baumgarten CR, Nichols RC, Naclerio RM, Proud D. Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis. J Immunol. 1986 Aug 15; 137(4):1323-8.
    View in: PubMed
    Score: 0.005
  79. Baumgarten CR, Nichols RC, Naclerio RM, Lichtenstein LM, Norman PS, Proud D. Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions. J Immunol. 1986 Aug 01; 137(3):977-82.
    View in: PubMed
    Score: 0.005
  80. Togias AG, Naclerio RM, Warner J, Proud D, Kagey-Sobotka A, Nimmagadda I, Norman PS, Lichtenstein LM. Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation. JAMA. 1986 Jan 10; 255(2):225-9.
    View in: PubMed
    Score: 0.005
  81. Creticos PS, Adkinson NF, Kagey-Sobotka A, Proud D, Meier HL, Naclerio RM, Lichtenstein LM, Norman PS. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest. 1985 Dec; 76(6):2247-53.
    View in: PubMed
    Score: 0.005
  82. Togias AG, Naclerio RM, Proud D, Fish JE, Adkinson NF, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985 Oct; 76(4):1375-81.
    View in: PubMed
    Score: 0.005
  83. Schleimer RP, Fox CC, Naclerio RM, Plaut M, Creticos PS, Togias AG, Warner JA, Kagey-Sobotka A, Lichtenstein LM. Role of human basophils and mast cells in the pathogenesis of allergic diseases. J Allergy Clin Immunol. 1985 Aug; 76(2 Pt 2):369-74.
    View in: PubMed
    Score: 0.005
  84. Baumgarten CR, Togias AG, Naclerio RM, Lichtenstein LM, Norman PS, Proud D. Influx of kininogens into nasal secretions after antigen challenge of allergic individuals. J Clin Invest. 1985 Jul; 76(1):191-7.
    View in: PubMed
    Score: 0.005
  85. Norman PS, Naclerio RM, Creticos PS, Togias A, Lichtenstein LM. Mediator release after allergic and physical nasal challenges. Int Arch Allergy Appl Immunol. 1985; 77(1-2):57-63.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.